ATE369135T1 - Behandlung von depression und zusammensetzungen dazu - Google Patents

Behandlung von depression und zusammensetzungen dazu

Info

Publication number
ATE369135T1
ATE369135T1 AT99918172T AT99918172T ATE369135T1 AT E369135 T1 ATE369135 T1 AT E369135T1 AT 99918172 T AT99918172 T AT 99918172T AT 99918172 T AT99918172 T AT 99918172T AT E369135 T1 ATE369135 T1 AT E369135T1
Authority
AT
Austria
Prior art keywords
depression
treatment
compositions
daily dose
folic acid
Prior art date
Application number
AT99918172T
Other languages
English (en)
Inventor
Alec James Coppen
Original Assignee
Scarista Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9808840A external-priority patent/GB2336534A/en
Priority claimed from GBGB9815372.9A external-priority patent/GB9815372D0/en
Application filed by Scarista Ltd filed Critical Scarista Ltd
Application granted granted Critical
Publication of ATE369135T1 publication Critical patent/ATE369135T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99918172T 1998-04-24 1999-04-23 Behandlung von depression und zusammensetzungen dazu ATE369135T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9808840A GB2336534A (en) 1998-04-24 1998-04-24 Anti-depressant - Folic Acid Combination
GBGB9815372.9A GB9815372D0 (en) 1998-07-15 1998-07-15 Treatment of depression and pharmaceutical preparations therefor

Publications (1)

Publication Number Publication Date
ATE369135T1 true ATE369135T1 (de) 2007-08-15

Family

ID=26313533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918172T ATE369135T1 (de) 1998-04-24 1999-04-23 Behandlung von depression und zusammensetzungen dazu

Country Status (14)

Country Link
EP (1) EP1071425B1 (de)
JP (1) JP2002512965A (de)
KR (1) KR100398791B1 (de)
AT (1) ATE369135T1 (de)
AU (1) AU765173B2 (de)
CA (1) CA2329665C (de)
DE (1) DE69936773T2 (de)
DK (1) DK1071425T3 (de)
ES (1) ES2292238T3 (de)
NO (1) NO20005341L (de)
NZ (1) NZ508310A (de)
PT (1) PT1071425E (de)
RU (1) RU2222329C2 (de)
WO (1) WO1999055338A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354547B (es) * 2011-11-14 2018-03-09 Alfasigma Spa Ensayos y métodos para seleccionar un regimen de tratamiento para un sujeto con depresión.
RU2717343C1 (ru) * 2019-03-01 2020-03-23 Евгений Владимирович Плотников Средство, обладающее цитопротекторным действием
CN113350375A (zh) * 2021-05-24 2021-09-07 北京斯利安药业有限公司 一种药用组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2072504B (en) * 1980-03-27 1983-10-26 Coppen A J Pharmaceutical compositions
DE3171821D1 (en) * 1981-10-05 1985-09-19 Alec James Coppen Pharmaceutical compositions
DE3856295T2 (de) * 1987-10-22 1999-06-17 Massachusetts Inst Technology Behandlung des prämenstruellen oder späten lutealsphase-syndroms
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки

Also Published As

Publication number Publication date
CA2329665C (en) 2007-09-04
AU3620399A (en) 1999-11-16
NO20005341D0 (no) 2000-10-23
EP1071425B1 (de) 2007-08-08
WO1999055338A1 (en) 1999-11-04
AU765173B2 (en) 2003-09-11
NO20005341L (no) 2000-12-08
DE69936773D1 (de) 2007-09-20
DK1071425T3 (da) 2007-12-27
PT1071425E (pt) 2007-11-16
JP2002512965A (ja) 2002-05-08
KR100398791B1 (ko) 2003-09-19
NZ508310A (en) 2005-03-24
DE69936773T2 (de) 2008-04-30
CA2329665A1 (en) 1999-11-04
KR20010072579A (ko) 2001-07-31
ES2292238T3 (es) 2008-03-01
RU2222329C2 (ru) 2004-01-27
EP1071425A1 (de) 2001-01-31

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
HUP0400529A2 (hu) Klórpromazin és pentamidin alkalmazása daganatképződéssel járó rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
HUP0402142A2 (hu) Kombinációs ösztrogén-gestagen készítmény és alkalmazása
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
PL365330A1 (en) Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp
BR0315927A (pt) Unidades para doses únicas diárias de melatonina
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
DE69936773D1 (de) Behandlung von depression und zusammensetzungen dazu
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
SE0102887D0 (sv) New formulation
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
SE0203817D0 (sv) New composition
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ITMI980356A1 (it) Composizioni orali a basso dosaggio di proteine citotossiche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1071425

Country of ref document: EP

REN Ceased due to non-payment of the annual fee